Wednesday 03 Sep, 2025 08:20 PM
Site map | Locate Us | Login
   Dev IT rallies after associate arm files IPO prospectus    Lupin gains after getting USFDA nod for Risperidone injection    Aarti Pharmalabs gains on commissioning phase 1 of new Gujarat facility    Globus Spirits Ltd leads losers in 'A' group    Caplin Point Lab gains after receiving USFDA nod for Milrinone Lactate injection    Arkade Developers gains after signing pact to acquire land in Bhandup West    Rajnish Wellness Ltd leads losers in 'B' group    Netweb Tech soars on Rs 1,734 crore AI infrastructure order    Volumes soar at TBO Tek Ltd counter    Biocon Ltd spurts 1.42%    Laurus Labs Ltd soars 1.7%    Vedanta Ltd gains for third straight session    JSW Steel Ltd up for third straight session    Hindustan Copper Ltd gains for third consecutive session    Steel Authority of India Ltd soars 3.83%, up for third straight session 
Saravan Stocks
       
Company News
Medistep Healthcare Ltd
NSE SME Medistep Healthcare takes a healthy first step, lists at a premium
Aug 18,2025   Hrs IST

The scrip was listed at Rs 53, a premium of 23.26% over the initial public offer (IPO) price. The stock is currently frozen at its lower limit of 5% over its listing price.

The counter hit a high of Rs 53 and a low of Rs 50.35. About 14.40 lakh shares of the company changed hands at the counter.

Medistep Healthcare's IPO was subscribed 356.34 times. The issue opened for bidding on 8 August 2025 and it closed on 12 August 2025. The price of the IPO was set at Rs 43 per share.

The IPO comprised fresh issue of 37,44,000 equity shares. The promoter and promoter group shareholding diluted to 68.96% from 93.62% pre-issue.

The company intends to utilize the net proceeds for funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility, working capital requirements and general corporate purpose.

Medistep Healthcare is a pharmaceutical company that has carved a niche in the Healthcare Industry through its experience in manufacturing Sanitary pads, Energy powder and trading a diverse range of pharmaceutical products, Nutraceutical products, Intimate Products and surgical products through distribution network. As of 20 July 2025, the company had total of 9 employees.

The company recorded revenue from operations of Rs 49.65 crore and net profit of Rs 4.14 crore for the period ended 31 March 2025.

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 43919291
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited